Teva seeks $25B to finance effort to take over Mylan

• Teva Pharmaceutical Industries (TEVA +1.5%) is reportedly seeking $25B in financing to help fund its bid for Mylan (MYL -1.1%). The company is rumored to be working on a higher offer after Mylan rejected its first bid of $40.1B.
• Previously: Mylan rejects $40B Teva bid (April 27)